查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2070369

牛疫苗市場規模、佔有率、成長、全球產業分析、區域洞察及2026-2034年預測。

Bovine Vaccines Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

牛隻疫苗市場成長要素

全球牛疫苗市場預計在2025年達到39億美元，2026年成長至40.4億美元，2034年達到63.2億美元，預測期間內複合年成長率（CAGR）為5.76%。該市場正穩步成長，主要受牛感染疾病流行、乳製品和肉品需求不斷成長以及人們對動物預防保健意識日益增強的推動。牛疫苗在保護牛免受口蹄疫、布氏桿菌症、出血性敗血症、黑蹄病和牛呼吸道疾病等疾病侵害方面發揮著至關重要的作用，有助於提高畜牧業生產力並改善糧食安全。

到 2025 年，北美將引領全球牛疫苗市場，佔市場總收入的 46.41%，這得益於其先進的獸醫基礎設施、大規模的商業牛和強大的疫苗接種計劃。

牛疫苗市場趨勢

市場的主要趨勢之一是鼻內接種和替代途徑疫苗接種技術的日益普及。畜牧養殖戶和獸醫越來越傾向於使用鼻內疫苗，特別是因為它們能迅速為牛提供針對呼吸道疾病的黏膜免疫力。這些疫苗易於接種，可減少注射部位反應，並在生命早期階段提供更好的感染疾病防護。

2025 年 10 月，默沙東動物保健公司報告稱，其經鼻吸入型疫苗BOVILIS NASALGEN-C 取得了積極成果，重點介紹了接種牛冠狀病毒疫苗的牛的生產性能的改善。

市場促進因素

政府擴大疫苗接種計劃

政府支持的疾病控制和疫苗接種工作正顯著推動市場成長。國家畜牧健康計畫透過大規模免疫接種宣傳活動和財政支持，提高了疫苗的供應量。這些計畫特別著重控制口蹄疫、布氏桿菌症和狂犬病等疾病，這些疾病會對畜牧業生產力和國際貿易造成嚴重影響。

例如，印度政府在 2025 年 1 月報告稱，根據國家計劃接種的疫苗累積數量將達到 107.34 億劑口蹄疫疫苗和 4.39 億劑布氏桿菌症疫苗，這表明政府積極參與疾病預防。

市場限制因素

供應鏈和分銷挑戰

儘管需求不斷成長，但疫苗市場在儲存、低溫運輸管理、運輸和最後一公里配送等方面仍面臨許多挑戰。維持疫苗品質需要嚴格的溫控物流系統，尤其是在偏遠的畜牧區。分銷網路不完善會降低疫苗效力並限制市場滲透率。

根據世界動物衛生組織（WOAH）2025 年動物衛生論壇的報告，疫苗供應持續受到分銷效率低、低溫運輸限制和獸醫基礎設施不足的影響。

市場機遇

活性化研發活動

獸用生物技術和疫苗研發投入的增加為市場擴張帶來了巨大的機會。研究人員正致力於開發先進疫苗，以提供更廣泛的保護並提高對影響牛的新興疾病的療效。

2024 年 8 月，密蘇里大學的研究人員研發出一種牛無形體病疫苗，這是一種嚴重的蜱傳疾病，會影響牛的健康和農業生產力。

市場挑戰

農民缺乏意識和疫苗接種率低

對完整疫苗接種計劃的認知不足仍然是一項重大挑戰。未能按時接種加強劑或遵循獸醫建議的疫苗接種計劃會降低疫苗效力並增加疾病發生率。在許多發展中地區，提高農民的疫苗接種意識並確保其遵守疫苗接種計劃仍然是影響市場成長的重要議題。

區域分析

北美洲

預計北美將繼續保持在區域市場的領先地位，到 2025 年市場規模將達到 18.1 億美元。該地區憑藉其大規模的牛數量、健全的預防保健措施以及對獸醫研究的大力投入等優勢，佔市場主導地位。

預計到 2026 年，美國牛疫苗市場規模將達到 17.5 億美元，約佔全球銷售額的 43.5%。

歐洲

預計到 2034 年，歐洲的年複合成長率將達到 5.78%。藍探戈病病例的增加、系統性的疫苗接種計劃以及強力的牛健康促進措施正在支持該地區的成長。

亞太地區

受大規模的牲畜數量和政府主導的疫苗接種計劃的推動，亞太地區預計到 2026 年將達到 5.4 億美元。

2026年各國具體預測如下：

  • 印度：1.8億美元
  • 中國：1.4億美元
  • 日本：2000萬美元

拉丁美洲、中東和非洲

由於牲畜疾病發病率上升以及政府主導的疫苗宣傳活動擴大，預計這些地區將保持穩定成長。拉丁美洲市場預計到2026年將達到3.5億美元，海灣合作理事會（GCC）市場預計為2,000萬美元。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家及地區牛病概況
  • 主要國家和地區的監管趨勢
  • 牛病疫苗接種概述
  • 新產品發布：按主要公司分類
  • 主要產業趨勢（合併、收購、合作等）

第5章：2021-2034年全球牛疫苗市場分析、洞察與預測

  • 市場分析、洞察與預測：按產品分類。
    • 失活
    • 削弱
    • 重組
    • 其他
  • 市場分析、洞察與預測：按給藥途徑
    • 口服
    • 腸外
    • 鼻腔
  • 市場分析、洞察與預測：按分銷管道分類
    • 動物醫院
    • 動物診所
    • 藥局/藥局
    • 其他
  • 分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美牛疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲牛疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區牛疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲牛疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲牛疫苗市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Boehringer Ingelheim International GmbH
    • Elanco
    • Zoetis Services LLC
    • Ceva
    • Virbac
    • Merck & Co., Inc.
    • HIPRA
    • Indian Immunologicals Ltd.
Product Code: FBI112837

Growth Factors of bovine vaccines Market

The global bovine vaccines market was valued at USD 3.90 billion in 2025 and is projected to grow from USD 4.04 billion in 2026 to USD 6.32 billion by 2034, registering a CAGR of 5.76% during the forecast period. The market is witnessing steady growth due to the increasing prevalence of infectious diseases among cattle, rising demand for dairy and meat products, and growing awareness regarding preventive animal healthcare. Bovine vaccines play a crucial role in protecting cattle from diseases such as Foot-and-Mouth Disease (FMD), brucellosis, hemorrhagic septicemia, black quarter, and bovine respiratory diseases, helping improve livestock productivity and food security.

North America dominated the global bovine vaccines market in 2025, accounting for 46.41% of total market revenue, supported by advanced veterinary healthcare infrastructure, large commercial cattle populations, and strong vaccination programs.

Bovine Vaccines Market Trends

A major trend shaping the market is the increasing adoption of intranasal and alternative-route vaccination technologies. Livestock producers and veterinarians are increasingly focusing on intranasal vaccines due to their ability to provide rapid mucosal immunity, especially against respiratory diseases in young calves. These vaccines offer easier administration, reduced injection-site reactions, and improved protection against early-life infections.

In October 2025, MSD Animal Health reported positive results from its BOVILIS NASALGEN-C intranasal vaccine, highlighting improved production outcomes in veal calves vaccinated against bovine coronavirus.

Market Drivers

Expansion of Government Vaccination Programs

Government-supported disease control and vaccination initiatives are significantly driving market growth. National livestock health programs are increasing vaccine accessibility through mass immunization campaigns and financial support. These programs are particularly focused on controlling diseases such as FMD, brucellosis, and rabies, which can severely impact livestock productivity and international trade.

For example, the Government of India reported in January 2025 that cumulative vaccination under national programs reached 107.34 crore doses for FMD and 4.39 crore doses for brucellosis, demonstrating strong government involvement in disease prevention.

Market Restraints

Supply Chain and Distribution Challenges

Despite increasing demand, the market faces challenges related to vaccine storage, cold-chain management, transportation, and last-mile delivery. Maintaining vaccine quality requires strict temperature-controlled logistics, particularly in remote cattle-rearing regions. Poor distribution networks can reduce vaccination effectiveness and limit market penetration.

According to WOAH's 2025 Animal Health Forum, vaccine accessibility continues to be affected by distribution inefficiencies, cold-chain limitations, and inadequate veterinary infrastructure.

Market Opportunities

Growing Research and Development Activities

Rising investments in veterinary biotechnology and vaccine development present significant opportunities for market expansion. Researchers are focusing on developing advanced vaccines that offer broader protection and improved efficacy against emerging diseases affecting cattle.

In August 2024, researchers at the University of Missouri developed a vaccine targeting bovine anaplasmosis, a serious tick-borne disease that affects cattle health and agricultural productivity.

Market Challenges

Low Farmer Awareness and Vaccination Compliance

Limited awareness regarding complete vaccination schedules remains a key challenge. Failure to follow booster doses and veterinarian-recommended vaccination timelines can reduce vaccine effectiveness and increase disease outbreaks. In many developing regions, farmer education and vaccination compliance continue to be major concerns affecting market growth.

Segment Analysis

By Product

The inactivated vaccines segment dominated the market in 2025 due to widespread use in dairy and beef cattle for respiratory, reproductive, and infectious disease prevention. Their proven safety profile and strong regulatory support contribute to their leadership position.

The recombinant vaccines segment is expected to witness the fastest growth, registering a CAGR of 9.52% during the forecast period due to advancements in biotechnology and improved vaccine efficacy.

By Route of Administration

The parenteral segment held the largest market share in 2025. Subcutaneous and intramuscular injections remain the preferred administration methods because they provide reliable immune responses, rapid protection, and established veterinary acceptance.

The intranasal segment is projected to grow at a CAGR of 8.65%, supported by increasing demand for respiratory disease prevention in calves.

By Distribution Channel

The veterinary clinics segment accounted for the largest market share in 2025. Veterinary clinics provide professional guidance on vaccination schedules, booster requirements, and disease management strategies, making them the preferred distribution channel among livestock producers.

The pharmacies and drug stores segment is expected to grow at a CAGR of 5.96% during the forecast period.

Regional Analysis

North America

North America remained the leading regional market, reaching USD 1.81 billion in 2025. The region benefits from a large cattle population, strong preventive healthcare practices, and robust veterinary research investments.

The U.S. bovine vaccines market is projected to reach USD 1.75 billion in 2026, accounting for approximately 43.5% of global revenue.

Europe

Europe is expected to grow at a CAGR of 5.78% through 2034. Increasing bluetongue outbreaks, structured vaccination programs, and strong cattle-health initiatives are supporting regional growth.

Asia Pacific

Asia Pacific is projected to reach USD 0.54 billion in 2026, driven by large livestock populations and expanding government vaccination programs.

Country-level projections for 2026 include:

  • India: USD 0.18 billion
  • China: USD 0.14 billion
  • Japan: USD 0.02 billion

Latin America and Middle East & Africa

These regions are expected to witness steady growth due to increasing livestock disease prevalence and expanding government-supported vaccination campaigns. Latin America is estimated to reach USD 0.35 billion in 2026, while the GCC market is projected at USD 0.02 billion.

Competitive Landscape

The bovine vaccines market is moderately competitive, with major players focusing on product innovation, manufacturing expansion, and strategic collaborations.

Leading companies include:

  • Zoetis Services LLC
  • Merck & Co., Inc.
  • HIPRA
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Ceva
  • Indian Immunologicals Ltd.

These companies continue to invest heavily in vaccine development, disease prevention technologies, and global market expansion strategies.

Key Industry Developments

  • March 2026: South Africa expanded its FMD vaccine sourcing framework through partnerships with multiple international suppliers.
  • July 2025: Elanco launched NUPLURA PH+5, a vaccine designed to protect calves from multiple respiratory diseases.
  • May 2025: Boehringer Ingelheim received market authorization in Germany for its BTV-3 vaccine.
  • May 2025: HIPRA launched HIPRABOVIS SOMNI/Lkt for bovine respiratory disease prevention.
  • February 2025: Elanco partnered with Medgene for commercialization of avian influenza vaccines in dairy cattle.

Conclusion

The global bovine vaccines market is positioned for sustained growth, increasing from USD 3.90 billion in 2025 to USD 4.04 billion in 2026, and reaching USD 6.32 billion by 2034. Growth is being driven by rising disease prevalence in cattle, expanding government vaccination initiatives, increasing demand for dairy and meat products, and continuous innovation in veterinary vaccine technologies. Although supply-chain challenges and low vaccination compliance remain concerns, ongoing R&D investments and improved disease-control programs are expected to strengthen market expansion throughout the forecast period.

Segmentation Product, Route of Administration, Distribution Channel, and Region

By Product * Inactivated

  • Live Attenuated
  • Recombinant
  • Others

By Route of Administration * Oral

  • Parenteral
  • Intranasal

By Distribution Channel * Veterinary Hospitals

  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region * North America (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)

    • U.S.
    • Canada
  • Europe (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Bovine Diseases by Key Countries, By Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario by Key Countries/ Region
  • 4.3. Overview of Vaccination for Bovine Diseases
  • 4.4. New Product Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.2.1. Oral
    • 5.2.2. Parenteral
    • 5.2.3. Intranasal
  • 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.3.1. Veterinary Hospitals
    • 5.3.2. Veterinary Clinics
    • 5.3.3. Pharmacies & Drug Stores
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.2.1. Oral
    • 6.2.2. Parenteral
    • 6.2.3. Intranasal
  • 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.3.1. Veterinary Hospitals
    • 6.3.2. Veterinary Clinics
    • 6.3.3. Pharmacies & Drug Stores
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.2.1. Oral
    • 7.2.2. Parenteral
    • 7.2.3. Intranasal
  • 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
    • 7.3.3. Pharmacies & Drug Stores
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.2.1. Oral
    • 8.2.2. Parenteral
    • 8.2.3. Intranasal
  • 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.3.1. Veterinary Hospitals
    • 8.3.2. Veterinary Clinics
    • 8.3.3. Pharmacies & Drug Stores
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.2.1. Oral
    • 9.2.2. Parenteral
    • 9.2.3. Intranasal
  • 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.3.1. Veterinary Hospitals
    • 9.3.2. Veterinary Clinics
    • 9.3.3. Pharmacies & Drug Stores
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.2.1. Oral
    • 10.2.2. Parenteral
    • 10.2.3. Intranasal
  • 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.3.1. Veterinary Hospitals
    • 10.3.2. Veterinary Clinics
    • 10.3.3. Pharmacies & Drug Stores
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of the Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Boehringer Ingelheim International GmbH
    • 11.2.2. Elanco
    • 11.2.3. Zoetis Services LLC
    • 11.2.4. Ceva
    • 11.2.5. Virbac
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. HIPRA
    • 11.2.8. Indian Immunologicals Ltd.

List of Tables

  • Figure 1: Global Bovine Vaccines Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 2: Global Bovine Vaccines Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Bovine Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 4: Global Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 5: Global Bovine Vaccines Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Bovine Vaccines Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 7: North America Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 8: North America Bovine Vaccines Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 9: North America Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 10: North America Bovine Vaccines Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 11: North America Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 12: North America Bovine Vaccines Market Value (USD Billion), By Country, 2025 & 2034
  • Figure 13: North America Bovine Vaccines Market Value Share (%), By Country, 2025
  • Figure 14: Europe Bovine Vaccines Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 15: Europe Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 16: Europe Bovine Vaccines Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 17: Europe Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 18: Europe Bovine Vaccines Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 19: Europe Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 20: Europe Bovine Vaccines Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Bovine Vaccines Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 24: Asia Pacific Bovine Vaccines Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 25: Asia Pacific Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 26: Asia Pacific Bovine Vaccines Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 27: Asia Pacific Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 28: Asia Pacific Bovine Vaccines Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Bovine Vaccines Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 31: Latin America Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 32: Latin America Bovine Vaccines Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 33: Latin America Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 34: Latin America Bovine Vaccines Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 35: Latin America Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 36: Latin America Bovine Vaccines Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Bovine Vaccines Market Value (USD Billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 40: Middle East & Africa Bovine Vaccines Market Value (USD Billion), by Route of Administration, 2025 & 2034
  • Figure 41: Middle East & Africa Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 42: Middle East & Africa Bovine Vaccines Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 43: Middle East & Africa Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 44: Middle East & Africa Bovine Vaccines Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Bovine Vaccines Market Share (%), By Company, 2025